Hyperhomocysteinemia: Impact on Neurodegenerative Diseases. - Wikidata - awgldk - TriplyDB

Hyperhomocysteinemia: Impact on Neurodegenerative Diseases.

Hyperhomocysteinemia: Impact on Neurodegenerative Diseases.

http://www.wikidata.org/entity/Q38513243

about

Therapies for Prevention and Treatment of Alzheimer's Disease Nrf2 mediates the protective effects of homocysteine by increasing the levels of GSH content in HepG2 cells Analysis of MTHFR, CBS, Glutathione, Taurine, and Hydrogen Sulfide Levels in Retinas of Hyperhomocysteinemic Mice.Five lipoxygenase hypomethylation mediates the homocysteine effect on Alzheimer's phenotype.The relationship between hyperhomocysteinemia and neurodegeneration.Serum levels of homocysteine, asymmetric dimethylarginine and nitric oxide in patients with Parkinson's disease.Sleep mediates the association between homocysteine and oxidative status in mild cognitive impairment.Homocysteine enhances the predictive value of the GRACE risk score in patients with ST-elevation myocardial infarction.Dissecting the Role of 5-Lipoxygenase in the Homocysteine-Induced Alzheimer's Disease Pathology.Synergistic Toxicity of the Neurometabolites Quinolinic Acid and Homocysteine in Cortical Neurons and Astrocytes: Implications in Alzheimer's Disease.Serum amino acid profile in patients with Parkinson's disease.Hydrogen sulfide attenuates homocysteine-induced cognitive deficits and neurochemical alterations by improving endogenous hydrogen sulfide levels.Intake of vitamin B before onset of Parkinson's disease and atypical parkinsonism and olfactory function at the time of diagnosis.Hyperhomocysteinemia Causes Chorioretinal Angiogenesis with Placental Growth Factor Upregulation

P2860

Q26740007-4AFC993E-FC9B-4881-9379-A1DBCE60D834 Q33828064-8AA90314-C77C-4B84-9BC8-63424C06E73C Q37738322-FC6FE3DD-6FF8-4C9C-A579-3075B72A9BAB Q37739453-1BE52A1B-E85C-4CDC-8092-2B8ED6C3BB1F Q38794990-1F95EB9E-1610-4B4E-8B14-9B87907F1272 Q39852913-4A8DCF14-3596-4E6C-B32B-3E21F1ECCBB8 Q41353649-AE9D644B-AC05-48A6-BC2B-1822D34F2357 Q45741016-F500B6A0-6B9B-4C40-AB46-8A866FFA0120 Q47280362-8B66AFC6-F290-4F2F-B023-3D999DCD1F17 Q47417741-306E7E92-A572-48BF-9C3E-1955DAB2B702 Q48043375-BE2C415A-04A7-4A75-B7F5-C3BA2426F7C4 Q50588439-2DD6B56F-2667-4C71-8AE2-4BF7FFCAC014 Q51782099-D61BA2F5-7801-4011-992C-92C0EDF7A0A7 Q58562948-2627A5A9-1F2F-4F49-83FD-C272B1530E2F

P2860

Hyperhomocysteinemia: Impact on Neurodegenerative Diseases.

http://www.wikidata.org/entity/Q38513243

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Hyperhomocysteinemia: Impact on Neurodegenerative Diseases.

@en

type

label

Hyperhomocysteinemia: Impact on Neurodegenerative Diseases.

@en

prefLabel

Hyperhomocysteinemia: Impact on Neurodegenerative Diseases.

@en

P1433

Q38513243-76C22131-9B5C-4862-AE3F-E7DED40C7354

P1476

Q38513243-7D48B022-5E3D-45EB-8EAD-596AB01D50EF

P2093

Q38513243-2BB811BD-DDC0-46F4-91ED-3ECD4393E85F

Q38513243-5316F5B5-463C-43D3-B4DC-B759B74C0156

Q38513243-8350722C-3B34-4942-8D81-7D5F9B986DAF

P2860

Q38513243-028EE675-CB9D-4035-BAD8-62F7F00C0517

Q38513243-0767C162-FE3F-4101-A932-2E142EACDBE4

Q38513243-12E9AFA6-6080-4067-92F3-410C7AD1636E

Q38513243-142F26D5-7601-4A32-8E94-5B9AFE086864

Q38513243-26DF609E-B713-42AD-91EB-BA221A2A3F1E

Q38513243-2ADDCD41-57FA-4493-9208-3FA4356AE05C

Q38513243-2FC3CDB6-D0C3-4BC3-B2D1-1F1207A48172

Q38513243-3057743F-43AC-4E78-92DC-C0DFA64A36EB

Q38513243-307B853B-5A83-4978-846D-DCECE3F19385

Q38513243-312028E7-CCDC-4701-9E92-676B9D103E99

P304

Q38513243-0D7844CD-B342-49E7-9ADE-E5987C865BA5

P31

Q38513243-D6D2A178-48D0-4BF5-A37E-A75CF8B1D50D

P356

Q38513243-7D5F4F0B-44F6-4D3B-BD6D-7D725B6C99DE

P433

Q38513243-6C995C45-2183-4E01-9BBC-469ACB44999D

P478

Q38513243-B5CAA212-3398-4FC2-9FDA-680316396B30

P577

Q38513243-A3530113-DCBE-4F9A-9AC2-84B5039353EE

P5875

Q38513243-59CA6E7D-04E5-4A6D-9264-03DC30C0A379

P698

Q38513243-48DBED6C-7E12-4A8E-981F-8C4C5FD13956

P921

Q38513243-1554A5AF-EFBA-4AC6-8B28-593C3BD0EC63

P356

P1433

Basic and Clinical Pharmacology and Toxicology

P1476

Hyperhomocysteinemia: Impact on Neurodegenerative Diseases.

@en

P2093

Manisha Tiwari

http://www.w3.org/2001/XMLSchema#string

Meenakshi Sharma

http://www.w3.org/2001/XMLSchema#string

Rakesh Kumar Tiwari

http://www.w3.org/2001/XMLSchema#string

P2860

Autism: many genes, common pathways?

Hyperhomocysteinemia due to methionine synthase deficiency, cblG: structure of the MTR gene, genotype diversity, and recognition of a common mutation, P1173L

Association of plasma total homocysteine levels with subclinical brain injury: cerebral volumes, white matter hyperintensity, and silent brain infarcts at volumetric magnetic resonance imaging in the Framingham Offspring Study

Increased glutamate and homocysteine and decreased glutamine levels in autism: a review and strategies for future studies of amino acids in autism

Alzheimer's disease-do tauists and baptists finally shake hands?

Huntington's disease

The methionine synthase reductase (MTRR) A66G polymorphism is a novel genetic determinant of plasma homocysteine concentrations

Induction of hyperhomocysteinemia models vascular dementia by induction of cerebral microhemorrhages and neuroinflammation.

Huntingtin interacts with cystathionine beta-synthase.

Resting brain perfusion and selected vascular risk factors in healthy elderly subjects.

P304

287-296

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/BCPT.12424

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

117

http://www.w3.org/2001/XMLSchema#string

P577

2015-06-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

277604433

http://www.w3.org/2001/XMLSchema#string

P698

26036286

http://www.w3.org/2001/XMLSchema#string

P921

neurodegeneration